5-272763-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_013232.4(PDCD6):c.154C>T(p.Leu52Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDCD6 | ENST00000264933.9 | c.154C>T | p.Leu52Phe | missense_variant | Exon 2 of 6 | 1 | NM_013232.4 | ENSP00000264933.4 | ||
ENSG00000286001 | ENST00000651543.1 | n.*1524C>T | non_coding_transcript_exon_variant | Exon 19 of 24 | ENSP00000499215.1 | |||||
PDCD6-AHRR | ENST00000675395.1 | n.154C>T | non_coding_transcript_exon_variant | Exon 2 of 14 | ENSP00000502570.1 | |||||
ENSG00000286001 | ENST00000651543.1 | n.*1524C>T | 3_prime_UTR_variant | Exon 19 of 24 | ENSP00000499215.1 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.91e-7 AC: 1AN: 1448102Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 720266
GnomAD4 genome Cov.: 27
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.154C>T (p.L52F) alteration is located in exon 2 (coding exon 2) of the PDCD6 gene. This alteration results from a C to T substitution at nucleotide position 154, causing the leucine (L) at amino acid position 52 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.